Projects per year
Personal profile
Biography
Mark Cooper AO is Professor of Diabetes and head of the Department of Diabetes within the Central Clinical School. His research and clinical interests are in diabetes and its complications, including kidney disease, heart disease and blindness.
Biography
Links:
- Department of Diabetes: www.med.monash.edu.au/cecs/diabetes/
- Professor Mark Cooper: www.med.monash.edu.au/cecs/diabetes/staff/cooper-mark.html
Keywords
- Diabetes
- Diabetic Complications
- kidney disease
- heart disease
- blindness
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2025
Finerenone in diabetic retinopathy
Wilkinson-Berka, J. & Cooper, M. E.
1/10/18 → 30/04/20
Project: Research
Targeting epigenetic pathways that lead to diabetic complications
Cooper, M. E., El-Osta, A., Jandeleit-Dahm, K. & Quaggin, S.
1/01/18 → 31/12/21
Project: Research
Boosting the immune system to treat diabetic retinopathy
Wilkinson-Berka, J., Mackay, F., Cooper, M. E., Lim, L. L. P. & Wickremasinghe, S.
1/10/17 → 30/09/20
Project: Research
Pharmacological inhibition of a novel target to reduce renal fibrosis
1/01/17 → 31/12/19
Project: Research
A novel endogenous inhibitor for the treatment of diabetic nephropathy
Cooper, M. E. & Kantharidis, P.
1/01/17 → 31/12/19
Project: Research
Research Output 1994 2018
Compression force sensing regulates integrin αiIbβ3 adhesive function on diabetic platelets
Ju, L., McFadyen, J. D., Al-Daher, S., Alwis, I., Chen, Y., Tønnesen, L. L., Maiocchi, S., Coulter, B., Calkin, A. C., Felner, E. I., Cohen, N., Yuan, Y., Schoenwaelder, S. M., Cooper, M. E., Zhu, C. & Jackson, S. P., 1 Dec 2018, In : Nature Communications. 9, 1, 16 p., 1087.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Diabetes reduces severity of aortic aneurysms depending on the presence of cell division autoantigen 1 (CDA1)
Li, J., Huynh, P., Dai, A., Wu, T., Tu, Y., Chow, B., Kiriazis, H., Du, X. J., Bach, L. A., Wilkinson-Berka, J. L., Biros, E., Walker, P., Nataatmadja, M., West, M., Golledge, J., Allen, T. J., Cooper, M. E. & Chai, Z., 1 Apr 2018, In : Diabetes. 67, 4, p. 755-768 14 p.Research output: Contribution to journal › Article › Research › peer-review
Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease
Brennan, E. P., Mohan, M., McClelland, A., Tikellis, C., Ziemann, M., Kaspi, A., Gray, S. P., Pickering, R., Tan, S. M., Tasadaque Ali-Shah, S., Guiry, P. J., El-Osta, A., Jandeleit-Dahm, K., Cooper, M. E., Godson, C. & Kantharidis, P., 1 May 2018, In : Journal of the American Society of Nephrology. 29, 5, p. 1437-1448 12 p.Research output: Contribution to journal › Article › Research › peer-review
Metabolic karma-the atherogenic legacy of diabetes: The 2017 edwin bierman award lecture
Cooper, M. E., El-Osta, A., Allen, T. J., Watson, A. M. D., Thomas, M. C. & Jandeleit-Dahm, K., 1 May 2018, In : Diabetes. 67, 5, p. 785-790 6 p.Research output: Contribution to journal › Article › Other
Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin
Cherney, D. Z. I., Cooper, M. E., Tikkanen, I., Pfarr, E., Johansen, O. E., Woerle, H-J., Broedl, U. C. & Lund, S. S., Jan 2018, In : Kidney International. 93, 1, p. 231-244 14 p.Research output: Contribution to journal › Article › Research › peer-review